PLPCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。PLP遺伝子サイレンサーは、PLP CRISPR/Cas9ノックアウトプラスミドとPLPDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のPLPCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
PLP CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PLP CRISPR/Cas9 KOプラスミド (h) | sc-401663 | h | Gene Knockout | GFP | 0 | ||
PLP HDRプラスミド (h) | sc-401663-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PLP Double Nickaseプラスミド (h) | sc-401663-NIC | h | Gene Knockout | Puromycin | 0 | ||
PLP Double Nickaseプラスミド (h2) | sc-401663-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PLP CRISPR/Cas9 KOプラスミド (m) | sc-422312 | m | Gene Knockout | GFP | 0 | ||
PLP HDRプラスミド (m) | sc-422312-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PLP Double Nickaseプラスミド (m) | sc-422312-NIC | m | Gene Knockout | Puromycin | 0 | ||
PLP Double Nickaseプラスミド (m2) | sc-422312-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
PLP2 CRISPR/Cas9 KOプラスミド (h) | sc-407045 | h | Gene Knockout | GFP | 0 | ||
PLP2 HDRプラスミド (h) | sc-407045-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
PLP2 Double Nickaseプラスミド (h) | sc-407045-NIC | h | Gene Knockout | Puromycin | 0 | ||
PLP2 Double Nickaseプラスミド (h2) | sc-407045-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
PLP2 CRISPR/Cas9 KOプラスミド (m) | sc-422313 | m | Gene Knockout | GFP | 0 | ||
PLP2 HDRプラスミド (m) | sc-422313-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
PLP2 Double Nickaseプラスミド (m) | sc-422313-NIC | m | Gene Knockout | Puromycin | 0 | ||
PLP2 Double Nickaseプラスミド (m2) | sc-422313-NIC-2 | m | Gene Knockout | Puromycin | 0 |
PLP CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
PLP CRISPR Activationプラスミド (h) | sc-401663-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP CRISPR Activationプラスミド (h2) | sc-401663-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP Lentiviral Activation Particles (h) | sc-401663-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP Lentiviral Activation Particles (h2) | sc-401663-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP CRISPR Activationプラスミド (m) | sc-422312-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP CRISPR Activationプラスミド (m2) | sc-422312-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP Lentiviral Activation Particles (m) | sc-422312-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP Lentiviral Activation Particles (m2) | sc-422312-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 CRISPR Activationプラスミド (h) | sc-407045-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 CRISPR Activationプラスミド (h2) | sc-407045-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 Lentiviral Activation Particles (h) | sc-407045-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 Lentiviral Activation Particles (h2) | sc-407045-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 CRISPR Activationプラスミド (m) | sc-422313-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 CRISPR Activationプラスミド (m2) | sc-422313-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 Lentiviral Activation Particles (m) | sc-422313-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
PLP2 Lentiviral Activation Particles (m2) | sc-422313-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |